Literature DB >> 18081000

The cannabinoid receptor agonist nabilone for the treatment of dementia-related agitation.

Michael J Passmore.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18081000     DOI： 10.1002/gps.1828

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN： 0885-6230            Impact factor:   3.485


× No keyword cloud information.
  22 in total

Review 1.  Cannabinoids for the Treatment of Agitation and Aggression in Alzheimer's Disease.

Authors:  Celina S Liu; Sarah A Chau; Myuri Ruthirakuhan; Krista L Lanctôt; Nathan Herrmann
Journal:  CNS Drugs       Date:  2015-08       Impact factor: 5.749

Review 2.  The Use of Cannabinoids in Treating Dementia.

Authors:  Megan Weier; Wayne Hall
Journal:  Curr Neurol Neurosci Rep       Date:  2017-08       Impact factor: 5.081

Review 3.  Alternatives to atypical antipsychotics for the management of dementia-related agitation.

Authors:  Michael J Passmore; David M Gardner; Yvette Polak; Kiran Rabheru
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

4.  Nabilone for the Treatment of Dementia-Associated Sexual Disinhibition.

Authors:  Daria M Zajac; Sarah R Sikkema; Ranjith Chandrasena
Journal:  Prim Care Companion CNS Disord       Date:  2015-02-19

Review 5.  Cannabinoids for Agitation in Alzheimer's Disease.

Authors:  John D Outen; M Haroon Burhanullah; Ryan Vandrey; Halima Amjad; David G Harper; Regan E Patrick; Rose L May; Marc E Agronin; Brent P Forester; Paul B Rosenberg
Journal:  Am J Geriatr Psychiatry       Date:  2021-01-27       Impact factor: 4.105

Review 6.  Endocannabinoid system in neurodegenerative disorders.

Authors:  Balapal S Basavarajappa; Madhu Shivakumar; Vikram Joshi; Shivakumar Subbanna
Journal:  J Neurochem       Date:  2017-07-05       Impact factor: 5.372

Review 7.  Cerebrovascular Complications Associated with Marijuana Use.

Authors:  Bayan Moustafa; Fernando D Testai
Journal:  Curr Neurol Neurosci Rep       Date:  2021-04-07       Impact factor: 5.081

Review 8.  Cannabis, a Miracle Drug with Polyvalent Therapeutic Utility: Preclinical and Clinical-Based Evidence.

Authors:  Rishabh Verma; Farazul Hoda; Mawrah Arshad; Asif Iqubal; Ali Nasir Siddiqui; Mohammad Ahmed Khan; Syed Ehtaishamul Haque; Mohd Akhtar; Abul Kalam Najmi
Journal:  Med Cannabis Cannabinoids       Date:  2021-05-21

Review 9.  Cannabinoids and the expanded endocannabinoid system in neurological disorders.

Authors:  Luigia Cristino; Tiziana Bisogno; Vincenzo Di Marzo
Journal:  Nat Rev Neurol       Date:  2019-12-12       Impact factor: 42.937

10.  Safety and Tolerability of Natural and Synthetic Cannabinoids in Older Adults: A Systematic Review and Meta-Analysis of Open-Label Trials and Observational Studies.

Authors:  Latha Velayudhan; Sagnik Bhattacharyya; Sara Pisani; Katie McGoohan
Journal:  Drugs Aging       Date:  2021-07-08       Impact factor: 3.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.